Cras ultrices nisl vitae fringilla iaculis. Integer tempor libero vel porttitor lobortis. Sed mattis metus enim, ac molestie dui fringilla in. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Donec consequat magna diam, nec sodales augue accumsan vitae.
The pressure on pharmacy benefit managers (PBMs) is ramping up. Both Congress and the Federal Trade Commission (FTC) are probing alleged anti-competitive practices by PBMs, and they’re doing so in parallel. Given the intense bipartisan pressure on PBMs, it’s increasingly likely that action of some kind will be taken to reform the drug pricing system.
Amid growing pressure from Congress to take a closer look at their business practices, the Federal Trade Commission plans to probe six of the largest pharmacy benefit managers in the U.S.
House Republicans have launched an investigation into the companies that manage drug benefits, dialing up the scrutiny of the middlemen who play an important role in how much medicines cost.